afraid that this stock soon tanks…. reason to worry?? as stated by yw23t..
no worries here.. dragon is sipping on cortadito and watching the tide roll in..
five products that are on the market and three that are in development… significant growth potential, particularly with uceris and glumetza..
late-stage products, ruconest and rifamycin, with estimated peak sales of about $200 million… two other indications for ruconest in planning... prophylactic treatment of HAE and acute pancreatitis which has huge upside potential..
positive early results for Uceris thus far… expecting revenues to exceed the upward-revised guidance…
it won’t tank soon as you stated.. it will continue to soar and will easily soar over $25.. first week of June or sooner.
we got cash, we go style, we got girls to make us smile… don’t worry, be happy..